Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Trinity Biotech Plc (TRIB)
NASDAQ:TRIB
Holding TRIB?
Track your performance easily
TRIB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.05 - $3.55
Previous Close$1.63
Volume67.14K
Average Volume (3M)1.37M
Market Cap
$18.53M
Enterprise Value$56.26M
Total Cash (Recent Filing)$6.58M
Total Debt (Recent Filing)$44.30M
Price to Earnings (P/E)―
Beta0.59
Next Earnings
Apr 02, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jun 05, 2015Dividend YieldN/A
Share Statistics
EPS (TTM)-2.68
Shares Outstanding9,465,514
10 Day Avg. Volume65,713
30 Day Avg. Volume1,370,547
Standard Deviation0.25
R-Squared0.05
Alpha0.00238
Financial Highlights & Ratios
Price to Book (P/B)-0.64
Price to Sales (P/S)0.27
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.99
Enterprise Value/Gross Profit2.55
Enterprise Value/Ebitda-8.02
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Trinity Biotech News
PremiumCompany Announcements
Trinity Biotech’s Q3 2024 Revenue and Strategic Growth
PremiumCompany Announcements
Trinity Biotech Secures Nasdaq Compliance, Eyes Growth
PremiumCompany Announcements
Trinity Biotech Acquires EpiCapture to Enter Oncology Market
PremiumCompany Announcements
Trinity Biotech Invests in Rapid Sepsis Testing InnovationOwnership Overview
―
Insiders
0.04% Mutual Funds
3.64% Other Institutional Investors
96.32% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
TRIB FAQ
What was Trinity Biotech Plc’s price range in the past 12 months?
Trinity Biotech Plc lowest stock price was $1.05 and its highest was $3.55 in the past 12 months.
What is Trinity Biotech Plc’s market cap?
Currently, no data Available
When is Trinity Biotech Plc’s upcoming earnings report date?
Trinity Biotech Plc’s upcoming earnings report date is Apr 02, 2025 which is in 127 days.
How were Trinity Biotech Plc’s earnings last quarter?
Trinity Biotech Plc released its earnings results on Aug 14, 2024. The company reported -$0.714 earnings per share for the quarter, missing the consensus estimate of -$0.67 by -$0.044.
Is Trinity Biotech Plc overvalued?
According to Wall Street analysts Trinity Biotech Plc’s price is currently Overvalued.
Does Trinity Biotech Plc pay dividends?
Trinity Biotech Plc pays a Annually dividend of $1.09 which represents an annual dividend yield of N/A. See more information on Trinity Biotech Plc dividends here
What is Trinity Biotech Plc’s EPS estimate?
Trinity Biotech Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Trinity Biotech Plc have?
Trinity Biotech Plc has 11,370,498 shares outstanding.
What happened to Trinity Biotech Plc’s price movement after its last earnings report?
Trinity Biotech Plc reported an EPS of -$0.714 in its last earnings report, missing expectations of -$0.67. Following the earnings report the stock price went up 2.846%.
Which hedge fund is a major shareholder of Trinity Biotech Plc?
Among the largest hedge funds holding Trinity Biotech Plc’s share is Perceptive Advisors LLC. It holds Trinity Biotech Plc’s shares valued at 4M.
---
Trinity Biotech Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 248.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 1.9%
Last 30 Days ▲ 0.7%
Last 30 Days ▲ 0.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-22.85%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
31.07%
Trailing 12-Months
Company Description
Trinity Biotech Plc
Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.
---
TRIB Earnings Call
Q2 2024
0:00 / 0:00
---
Technical Analysis
---